Found: 76
Select item for more details and to access through your institution.
The role of thymic stromal lymphopoietin in cutaneous disorders.
- Published in:
- Archives of Dermatological Research, 2024, v. 316, n. 5, p. 1, doi. 10.1007/s00403-024-02866-9
- By:
- Publication type:
- Article
Investigator- and patient-rated local tolerability in phase 3 trials of topical roflumilast in patients with psoriasis, seborrheic dermatitis, and atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii9, doi. 10.1093/bjd/ljad498.012
- By:
- Publication type:
- Article
Tapinarof cream 1% once daily: significant efficacy in the treatment of atopic dermatitis in two pivotal phase 3 trials in adults and children down to 2 years of age.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii17, doi. 10.1093/bjd/ljad498.021
- By:
- Publication type:
- Article
Rapid and early onset of itch relief with tapinarof cream 1% once daily in two pivotal phase 3 trials in adults and children down to two years of age with atopic dermatitis.
- Published in:
- British Journal of Dermatology, 2024, v. 190, p. ii18, doi. 10.1093/bjd/ljad498.022
- By:
- Publication type:
- Article
Efficacy and safety of ritlecitinib in adolescents with alopecia areata: Results from the ALLEGRO phase 2b/3 randomized, double‐blind, placebo‐controlled trial.
- Published in:
- Pediatric Dermatology, 2023, v. 40, n. 6, p. 1003, doi. 10.1111/pde.15378
- By:
- Publication type:
- Article
Methotrexate for inflammatory skin disease in pediatric patients: Consensus treatment guidelines.
- Published in:
- Pediatric Dermatology, 2023, v. 40, n. 5, p. 789, doi. 10.1111/pde.15327
- By:
- Publication type:
- Article
Molluscum Contagiosum: Epidemiology, Considerations, Treatment Options, and Therapeutic Gaps.
- Published in:
- Journal of Clinical & Aesthetic Dermatology, 2023, v. 16, p. S4
- By:
- Publication type:
- Article
Comprehensive Management of Molluscum Contagiosum: Assessment of Clinical Associations, Comorbidities, and Management Principles.
- Published in:
- Journal of Clinical & Aesthetic Dermatology, 2023, v. 16, p. S12
- By:
- Publication type:
- Article
402 Efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: 16-week results from three randomized phase 3 clinical trials.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. 1, doi. 10.1093/bjd/ljad162.025
- By:
- Publication type:
- Article
406 Tapinarof cream 1% once daily for the treatment of extensive atopic dermatitis in adolescents and children: outcomes from the 4-week maximal usage trial.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. 1, doi. 10.1093/bjd/ljad162.028
- By:
- Publication type:
- Article
390 Efficacy and safety of roflumilast cream 0.15% in adults and children aged ≥6 years with mild to moderate atopic dermatitis in two phase 3 trials (INTEGUMENT-1 and INTEGUMENT-2).
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. 1, doi. 10.1093/bjd/ljad162.016
- By:
- Publication type:
- Article
Roflumilast Cream vs Vehicle Cream and Chronic Plaque Psoriasis—Reply.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 329, n. 7, p. 595, doi. 10.1001/jama.2022.22649
- By:
- Publication type:
- Article
301 Tapinarof cream 1% once daily for the treatment of extensive atopic dermatitis in adolescents and children: 4-week maximal use trial.
- Published in:
- British Journal of Dermatology, 2023, v. 188, p. ii3, doi. 10.1093/bjd/ljac140.005
- By:
- Publication type:
- Article
Topical Antibiotic Treatment in Dermatology.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 2, p. 188, doi. 10.3390/antibiotics12020188
- By:
- Publication type:
- Article
Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials.
- Published in:
- JAMA: Journal of the American Medical Association, 2022, v. 328, n. 11, p. 1073, doi. 10.1001/jama.2022.15632
- By:
- Publication type:
- Article
Real-World Evidence of an Emollient Device for Atopic and Contact Dermatitis in Pediatric to Adult Patients – Data from a Post-Marketing Surveillance.
- Published in:
- Clinical, Cosmetic & Investigational Dermatology, 2022, v. 15, p. 1797, doi. 10.2147/CCID.S364934
- By:
- Publication type:
- Article
Evaluation of Psychological Wellbeing and Social Impact of Combined Facial and Truncal Acne: a Multi-national, Mixed-Methods Study.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 8, p. 1847, doi. 10.1007/s13555-022-00768-0
- By:
- Publication type:
- Article
Efficacy and Safety of Topical Nitric Oxide-Releasing Berdazimer Gel in Patients With Molluscum Contagiosum: A Phase 3 Randomized Clinical Trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The New Face of Preadolescent and Adolescent Acne: Beyond the Guidelines.
- Published in:
- Journal of Family Practice, 2022, v. 71, n. 6, p. S63, doi. 10.12788/jfp.0430
- By:
- Publication type:
- Article
Efficacy and Safety of an Antioxidant-Enriched Medical Device for Topical Use in Adults with Eczematous Dermatitis.
- Published in:
- Dermatology & Therapy, 2022, v. 12, n. 4, p. 1015, doi. 10.1007/s13555-022-00705-1
- By:
- Publication type:
- Article
Subgroup Analysis of Crisaborole for Mild-to-Moderate Atopic Dermatitis in Children Aged 2 to < 18 Years.
- Published in:
- Pediatric Drugs, 2022, v. 24, n. 2, p. 175, doi. 10.1007/s40272-021-00490-y
- By:
- Publication type:
- Article
Impact of Facial Atrophic Acne Scars on Quality of Life: A Multi-country Population-Based Survey.
- Published in:
- American Journal of Clinical Dermatology, 2022, v. 23, n. 1, p. 115, doi. 10.1007/s40257-021-00628-1
- By:
- Publication type:
- Article
Higher rates of skin clearance and efficacy in challenging body areas are associated with better health‐related quality of life following ixekizumab maintenance treatment in pediatric patients with plaque psoriasis.
- Published in:
- Pediatric Dermatology, 2022, v. 39, n. 1, p. 55, doi. 10.1111/pde.14892
- By:
- Publication type:
- Article
Efficacy and Safety Trends with Continuous, Long-Term Crisaborole Use in Patients Aged ≥ 2 Years with Mild-to-Moderate Atopic Dermatitis.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 5, p. 1667, doi. 10.1007/s13555-021-00584-y
- By:
- Publication type:
- Article
Correction to: Efficacy and Safety Trends with Continuous, Long-Term Crisaborole Use in Patients Aged ≥ 2 Years with Mild-to-Moderate Atopic Dermatitis.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Primary hyperhidrosis in children: A review of therapeutics.
- Published in:
- Pediatric Dermatology, 2021, v. 38, n. 3, p. 561, doi. 10.1111/pde.14551
- By:
- Publication type:
- Article
Once-daily Dapsone 7.5% Gel for the Treatment of Acne Vulgaris in Preadolescent Patients: A Phase IV, Open-label, 12-week Study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Efficacy of Nonprescription Moisturizers for Atopic Dermatitis: An Updated Review of Clinical Evidence.
- Published in:
- American Journal of Clinical Dermatology, 2020, v. 21, n. 5, p. 641, doi. 10.1007/s40257-020-00529-9
- By:
- Publication type:
- Article
Efficacy and Safety of Topical Clascoterone Cream, 1%, for Treatment in Patients With Facial Acne: Two Phase 3 Randomized Clinical Trials.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The Use of TNFα Inhibitors in Treating Pediatric Skin Disorders.
- Published in:
- Pediatric Drugs, 2020, v. 22, n. 3, p. 311, doi. 10.1007/s40272-020-00394-3
- By:
- Publication type:
- Article
Long‐term efficacy and safety of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Post hoc pediatric subgroup analysis from a 44‐week open‐label extension study.
- Published in:
- Pediatric Dermatology, 2020, v. 37, n. 3, p. 490, doi. 10.1111/pde.14135
- By:
- Publication type:
- Article
Recent Advances in the Treatment and Management of Moderate-to-Severe Atopic Dermatitis: What's New in Biologic Therapies.
- Published in:
- Journal of Managed Care Medicine, 2020, v. 23, n. 1, p. 44
- By:
- Publication type:
- Article
A 44-Week Open-Label Study Evaluating Safety and Efficacy of Topical Glycopyrronium Tosylate in Patients with Primary Axillary Hyperhidrosis.
- Published in:
- American Journal of Clinical Dermatology, 2019, v. 20, n. 4, p. 593, doi. 10.1007/s40257-019-00446-6
- By:
- Publication type:
- Article
Sodium hypochlorite body wash in the management of Staphylococcus aureus–colonized moderate‐to‐severe atopic dermatitis in infants, children, and adolescents.
- Published in:
- Pediatric Dermatology, 2019, v. 36, n. 4, p. 442, doi. 10.1111/pde.13842
- By:
- Publication type:
- Article
Topical Glycopyrronium Tosylate for the Treatment of Primary Axillary Hyperhidrosis: Patient-Reported Outcomes from the ATMOS-1 and ATMOS-2 Phase III Randomized Controlled Trials.
- Published in:
- American Journal of Clinical Dermatology, 2019, v. 20, n. 1, p. 135, doi. 10.1007/s40257-018-0395-0
- By:
- Publication type:
- Article
Glycopyrronium tosylate in pediatric primary axillary hyperhidrosis: Post hoc analysis of efficacy and safety findings by age from two phase three randomized controlled trials.
- Published in:
- Pediatric Dermatology, 2019, v. 36, n. 1, p. 89, doi. 10.1111/pde.13723
- By:
- Publication type:
- Article
Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis-1 with Everolimus: A Phase II, Open-Label, Single-Arm Trial.
- Published in:
- Drugs in R&D, 2018, v. 18, n. 4, p. 295, doi. 10.1007/s40268-018-0248-6
- By:
- Publication type:
- Article
The cutaneous manifestations of tuberous sclerosis complex.
- Published in:
- American Journal of Medical Genetics. Part C: Seminars in Medical Genetics, 2018, v. 178, n. 3, p. 321, doi. 10.1002/ajmg.c.31649
- By:
- Publication type:
- Article
Efficacy and Safety of Topical Rapamycin in Patients With Facial Angiofibromas Secondary to Tuberous Sclerosis Complex: The TREATMENT Randomized Clinical Trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Efficacy and Safety of Ozenoxacin Cream for Treatment of Adult and Pediatric Patients With Impetigo: A Randomized Clinical Trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Developing drugs for treatment of atopic dermatitis in children (≥3 months to <18 years of age): Draft guidance for industry.
- Published in:
- Pediatric Dermatology, 2018, v. 35, n. 3, p. 303, doi. 10.1111/pde.13452
- By:
- Publication type:
- Article
Pediatric psoriasis: Evolving perspectives.
- Published in:
- Pediatric Dermatology, 2018, v. 35, n. 2, p. 170, doi. 10.1111/pde.13382
- By:
- Publication type:
- Article
What is New in the Evolving Treatment Landscape for Moderate to Severe Atopic Dermatitis?
- Published in:
- Journal of Managed Care Medicine, 2018, v. 21, n. 1, p. 47
- By:
- Publication type:
- Article
Current and Emerging Medical Therapies for Primary Hyperhidrosis.
- Published in:
- Dermatology & Therapy, 2017, v. 7, n. 1, p. 25, doi. 10.1007/s13555-016-0148-z
- By:
- Publication type:
- Article
Crisaborole Topical Ointment, 2% in Patients Ages 2 to 17 Years with Atopic Dermatitis: A Phase 1b, Open-Label, Maximal-Use Systemic Exposure Study.
- Published in:
- Pediatric Dermatology, 2016, v. 33, n. 4, p. 380, doi. 10.1111/pde.12872
- By:
- Publication type:
- Article
Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A Prospective, Nonrandomized, Open-Label Study of the Efficacy and Safety of OnabotulinumtoxinA in Adolescents with Primary Axillary Hyperhidrosis.
- Published in:
- Pediatric Dermatology, 2015, v. 32, n. 5, p. 609, doi. 10.1111/pde.12620
- By:
- Publication type:
- Article
Pimecrolimus in atopic dermatitis: Consensus on safety and the need to allow use in infants.
- Published in:
- Pediatric Allergy & Immunology, 2015, v. 26, n. 4, p. 306, doi. 10.1111/pai.12331
- By:
- Publication type:
- Article
Dermatologic and Dental Aspects of the 2012 International Tuberous Sclerosis Complex Consensus Statements.
- Published in:
- JAMA Dermatology, 2014, v. 150, n. 10, p. 1095, doi. 10.1001/jamadermatol.2014.938
- By:
- Publication type:
- Article
Maximal Use Systemic Exposure (MUSE) Study Evaluating AN2728 Ointment, 2%, a Novel Boron-based Small Molecule, for the Treatment of Pediatric and Adolescent Subjects with Mild-to-Moderate Atopic Dermatitis.
- Published in:
- 2014
- By:
- Publication type:
- Abstract